PMID- 24956991 OWN - NLM STAT- MEDLINE DCOM- 20150723 LR - 20211203 IS - 1778-7254 (Electronic) IS - 1297-319X (Linking) VI - 81 IP - 6 DP - 2014 Dec TI - Increased RANKL-mediated osteoclastogenesis by interleukin-1beta and endoplasmic reticulum stress. PG - 520-6 LID - S1297-319X(14)00132-8 [pii] LID - 10.1016/j.jbspin.2014.04.012 [doi] AB - OBJECTIVE: The mechanism by which IL-1beta and thapsigargin (TG)-induced endoplasmic reticulum (ER) stress modulate the receptor activator of nuclear factor kappa-B ligand (RANKL)-mediated osteoclastogenesis remains elusive. Thus, we investigated the osteoclast-specific and ER signals in osteoclastogenesis of bone marrow-derived cells. METHODS: Bone marrow cells (BMCs) were obtained from 5-week-old male ICR mice and cultured to be differentiated into osteoclasts with M-CSF and RANKL in the presence or absence of IL-1beta, TG, or 4-phenylbutyric acid (PBA), an ER stress-reducing drug. The formation of osteoclasts was evaluated by tartrate-resistant acid phosphatase (TRAP) staining and resorption pit assay with a dentine slice. The molecular mechanism of IL-1beta and ER stress in osteoclastogenesis was investigated in BMCs transfected with siRNA for GRP78, PERK and IRE1 using reverse transcription-polymerase chain reaction and immunoblotting for osteoclast-specific and ER stress signaling molecules. RESULTS: IL-1beta and ER stress induced by TG-augmented the formation of osteoclasts, which was significantly inhibited by PBA and was mediated with osteoclast-specific signals, including c-Fos, NFATc1, and ER stress- associated signaling pathways, such as PERK, IRE1, GRP78, and eIF2alpha. siRNA-mediated knockdown of ER stress signals inhibited the expression of NFATc1 and c-Fos, thus reducing IL-1beta and/or TG-induced formation of osteoclasts. CONCLUSIONS: Osteoclastogenesis by IL-1beta and/or ER stress is mainly associated with upregulation of eIF2alpha, GRP78, PERK and IRE1. These results suggest that the signaling pathway of ER stress-induced osteoclast formation might be a new therapeutic target to prevent inflammatory and destructive arthritic disease such as RA and diverse osteoporosis. CI - Copyright (c) 2014 Societe francaise de rhumatologie. Published by Elsevier SAS. All rights reserved. FAU - Lee, Eun-Gyeong AU - Lee EG AD - Department of Internal Medicine, Medical School and Research Institute of Clinical Medicine, Chonbuk National University and Chonbuk, National University Hospital, Jeonju, Jeonbuk 561-712, South Korea. FAU - Sung, Myung-Soon AU - Sung MS AD - Department of Internal Medicine, Medical School and Research Institute of Clinical Medicine, Chonbuk National University and Chonbuk, National University Hospital, Jeonju, Jeonbuk 561-712, South Korea. FAU - Yoo, Han-Gyul AU - Yoo HG AD - Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston RI 02881, United States of America. FAU - Chae, Han-Jung AU - Chae HJ AD - Department of Pharmacology, Chonbuk National University Medical School, Jeonju, Jeonbuk 561-712, South Korea. FAU - Kim, Hang-Rae AU - Kim HR AD - Department of Anatomy, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, South Korea. FAU - Yoo, Wan-Hee AU - Yoo WH AD - Department of Internal Medicine, Medical School and Research Institute of Clinical Medicine, Chonbuk National University and Chonbuk, National University Hospital, Jeonju, Jeonbuk 561-712, South Korea. Electronic address: ywhim@jbnu.ac.kr. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140620 PL - France TA - Joint Bone Spine JT - Joint bone spine JID - 100938016 RN - 0 (Endoplasmic Reticulum Chaperone BiP) RN - 0 (Enzyme Inhibitors) RN - 0 (Hspa5 protein, mouse) RN - 0 (Interleukin-1beta) RN - 0 (Phenylbutyrates) RN - 0 (RANK Ligand) RN - 67526-95-8 (Thapsigargin) RN - 7WY7YBI87E (4-phenylbutyric acid) SB - IM MH - Animals MH - Bone Marrow Cells/*metabolism MH - Cell Differentiation MH - Endoplasmic Reticulum Chaperone BiP MH - Endoplasmic Reticulum Stress/*physiology MH - Enzyme Inhibitors/pharmacology MH - Interleukin-1beta/*metabolism MH - Macrophages/metabolism MH - Male MH - Mice MH - Mice, Inbred ICR MH - Models, Animal MH - Osteoclasts/drug effects/*physiology MH - Phenylbutyrates MH - RANK Ligand/*metabolism MH - Signal Transduction MH - Thapsigargin/pharmacology OTO - NOTNLM OT - 4-phenylbutyric acid OT - Endoplasmic reticulum stress OT - IL-1beta OT - Osteoclast OT - Thapsigargin EDAT- 2014/06/25 06:00 MHDA- 2015/07/24 06:00 CRDT- 2014/06/25 06:00 PHST- 2013/08/25 00:00 [received] PHST- 2014/04/24 00:00 [accepted] PHST- 2014/06/25 06:00 [entrez] PHST- 2014/06/25 06:00 [pubmed] PHST- 2015/07/24 06:00 [medline] AID - S1297-319X(14)00132-8 [pii] AID - 10.1016/j.jbspin.2014.04.012 [doi] PST - ppublish SO - Joint Bone Spine. 2014 Dec;81(6):520-6. doi: 10.1016/j.jbspin.2014.04.012. Epub 2014 Jun 20.